LINC01974: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01974

NCBI ID: G105371798

LINC01974

Other Name(s): long intergenic non-protein coding RNA 1974 | LINC01974 variant X1 | Long intergenic non-protein coding RNA 1974, transcript variant X1

LINC01974: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC01974 is a long non-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to play a key role in the regulation of gene expression and has been associated with various diseases, including cancer. As a result, LINC01974 has gained significant interest as a potential drug target or biomarker.

Disease-Related Functions of LINC01974

LINC01974 has been shown to be involved in the regulation of gene expression in various organisms, including humans. Studies have shown that LINC01974 can interact with various transcription factors, including RNA factors, DNA-binding proteins, and chromatin modifiers. LINC01974 has also been shown to play a role in the regulation of protein translation, which is critical for the development and progression of many diseases.

In addition to its role in gene expression and protein translation, LINC01974 has also been shown to be involved in the regulation of cellular processes that are critical for the survival of organisms, including the regulation of cell growth, apoptosis, and inflammation. These functions have led to the hypothesis that LINC01974 may be a potential drug target or biomarker for various diseases.

Potential Therapeutic Applications of LINC01974

The potential therapeutic applications of LINC01974 are vast and varied. As a drug target, LINC01974 may be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. LINC01974 has also been shown to be involved in the regulation of gene expression in diseases that are associated with protein misfolding, such as Alzheimer's disease and Parkinson's disease. As a biomarker, LINC01974 may be used to diagnose and monitor the progression of these diseases.

In addition to its potential therapeutic applications, LINC01974 has also been shown to be involved in the regulation of stem cell proliferation and differentiation, which may have implications for the development of cancer therapies. LINC01974 has also been shown to play a role in the regulation of immune responses, which may have implications for the development of vaccines and immunotherapies.

Conclusion

LINC01974 is a long non-coding RNA that has been shown to play a key role in the regulation of gene expression and has been associated with various diseases. Its functions as a drug target or biomarker are vast and varied, and its potential therapeutic applications are significant. Further research is needed to fully understand the role of LINC01974 in the regulation of gene expression and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1974

The "LINC01974 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01974 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets